Form 4: Ideaya Biosciences Executive Exercises Stock Options

Jason Throne, Chief Legal Officer of Ideaya Biosciences, exercised stock options on June 27, 2024, acquiring a total of 53,484 shares of common stock.

Summary

• On June 27, 2024, Jason Throne, the Chief Legal Officer of Ideaya Biosciences, exercised stock options.
• He acquired 6,424 shares of common stock at a price of $13.34 per share.
• Additionally, he acquired 47,060 shares of common stock at a price of $7.01 per share.
• Following these transactions, Throne directly owns 63,484 shares of Ideaya Biosciences common stock.
• He also holds options to purchase 41,186 shares at $13.34 and 1,360 shares at $7.01.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a routine transaction. The executive exercising options suggests confidence, but it's not a major event.

Positives

• The exercise of stock options by a company executive can be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

Executive stock option exercises are a common practice in publicly traded companies, particularly in the biotechnology sector, as a means of incentivizing and retaining key personnel.

Comparison to Industry Standards

• Stock option grants and exercises are standard components of executive compensation packages in the biotech industry.
• Companies like Amgen, Gilead, and Regeneron also utilize stock options to align executive interests with shareholder value.

Stakeholder Impact

• The transaction could have a minor impact on shareholders due to the increase in the number of outstanding shares.

Key Dates